Oramed Pharmaceuticals (ORMP) Balance Sheet: Assets & Liabilities

Oramed Pharmaceuticals (ORMP) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Oramed Pharmaceuticals reported total assets of $230.86M and total liabilities of $31.12M. Shareholders' equity was $199.74M, up 36.6% from $146.26M a year earlier. Total debt stood at $825.00K against $125.89M in cash and short-term investments, a net cash position of $125.07M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Oramed Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Oramed Pharmaceuticals Inc. (ORMP) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period ending	Dec 2025	Dec 2024	Dec 2023	Sep 2023	Dec 2022	Dec 2021	Aug 2021	Aug 2020	Aug 2019	Aug 2018	Aug 2017	Aug 2012
Current Assets
Cash and Cash Equivalents	45.95	54.42	9.06	9.06	40.46	27.46	77.25	19.30	3.33	5.00	3.97	4.43
Short-Term Investments	79.95	87.51	152.99	152.99	115.26	118.82	16.90	20.60	28.95	25.47	16.15	0.65
Cash & Short-Term Investments	125.89	141.93	162.05	162.05	155.72	146.28	94.14	39.90	32.28	30.46	20.12	5.09
Accounts Receivable	4.64	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	-
Inventory	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	-
Other Current Assets	2.74	1.29	0.54	0.54	1.39	1.66	1.20	0.61	1.04	0.57	0.16	2.32
Total Current Assets	133.27	143.22	162.58	162.58	157.11	147.94	95.34	40.51	33.32	31.04	20.30	5.28
Non-Current Assets
Property, Plant & Equipment (Net)	1.34	1.11	1.57	1.57	1.80	0.89	0.93	0.18	0.02	0.02	0.02	0.00
Long-Term Investments	71.62	10.91	56.37	56.37	2.70	3.88	6.69	3.93	1.30	16.33	18.38	-
Other Non-Current Assets	0.05	0.03	0.03	0.03	0.03	25.12	25.04	0.02	0.02	0.02	0.02	0.01
Total Non-Current Assets	97.59	12.06	57.97	57.97	4.53	-	32.66	4.12	1.34	16.36	18.42	-
Total Assets	230.86	155.28	220.55	220.55	161.64	177.82	128.00	44.63	34.66	47.40	38.71	5.29
Current Liabilities
Accounts Payable	0.44	0.79	0.55	0.55	2.18	4.54	2.61	0.59	1.34	1.14	0.57	0.64
Short-Term Debt	0.29	0.22	51.01	51.28	0.25	-	0.13	0.04	0.00	0.00	0.00	-
Accrued Liabilities	2.47	1.15	1.06	-	1.97	1.20	1.19	-	-	-	-	-
Deferred Revenue	1.35	0.00	-	0.00	1.34	2.70	2.70	2.70	2.70	2.45	2.45	-
Other Current Liabilities	10.60	1.48	-	1.38	1.98	0.04	1.24	1.20	-0.07	-0.17	1.57	-
Total Current Liabilities	19.09	5.69	53.21	53.21	5.75	7.37	6.68	4.54	5.31	4.55	5.17	0.64
Non-Current Liabilities
Long-Term Debt	0.54	0.16	0.34	0.34	0.65	-	0.40	0.03	-5.63	-7.82	0.02	-
Deferred Tax Liabilities	7.91	0.00	0.01	0.00	0.01	-	0.01	0.01	0.01	0.01	0.01	-
Other Non-Current Liabilities	11.49	0.09	0.06	0.10	0.08	3.47	0.15	0.23	5.92	8.15	0.44	0.87
Total Non-Current Liabilities	12.03	4.25	4.44	4.44	4.74	3.84	4.80	7.22	9.96	11.73	14.31	0.87
Total Liabilities	31.12	9.93	57.66	57.66	10.49	11.21	11.48	11.75	15.27	16.29	19.47	1.52
Stockholders' Equity
Common Stock	0.47	0.48	0.49	0.49	0.48	0.46	0.42	0.28	0.21	0.21	0.16	0.08
Retained Earnings	-123.44	-176.62	-157.56	-157.56	-163.08	-126.52	-114.85	-92.61	-81.10	-69.22	-56.50	-17.89
Accumulated Other Comprehensive Income	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.70	0.40	-
Additional Paid-in Capital	322.71	322.40	320.89	320.89	314.42	-	230.20	125.21	100.29	99.43	75.17	-
Minority Interest	0.00	-0.92	-0.93	-0.93	-0.66	-	0.74	0.00	0.00	0.00	0.00	-
Shares Outstanding	39.28	39.92	40.34	-	39.56	-	35.29	-	-	-	-	-
Total Stockholders' Equity	199.74	146.27	163.82	163.82	151.81	166.61	115.77	32.88	19.39	31.11	19.24	3.78
Total Liabilities & Equity	230.86	155.28	220.55	220.55	161.64	-	128.00	44.63	34.66	47.40	38.71	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Oramed Pharmaceuticals Balance Sheet

How much debt does Oramed Pharmaceuticals have?

Oramed Pharmaceuticals had total debt of $825.00K as of Dec 31, 2025, against $125.89M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $372.00K a year earlier.

What are Oramed Pharmaceuticals's total assets?

Oramed Pharmaceuticals reported total assets of $230.86M as of Dec 31, 2025, up 48.7% from $155.28M a year earlier. Total liabilities were $31.12M.

What is Oramed Pharmaceuticals's shareholders' equity?

Oramed Pharmaceuticals's shareholders' equity was $199.74M as of Dec 31, 2025, or about $5.09 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition